Home » Authors » Diana Tucker

Diana Tucker

Articles

ARTICLES

... physician ... surgeon ... ENTREPRENEUR

Nov. 1, 2007

By Diana Tucker

Bariatric market big enough for variety of new entrants

Aug. 1, 2007

By Diana Tucker

New gastric bypass procedures address the fears of surgery

July 5, 2007

By Diana Tucker

Bariatric market big enough for a variety of new entrants

July 3, 2007

By Diana Tucker

Following lumpectomy many new options are now offered for women

July 1, 2007

By Diana Tucker

Market & technology updates: ‘Lifestyle’ medicine — driven by big dollars and increasing risk

June 1, 2007

By Diana Tucker

Endolumenal systems providing advanced incisionless surgery

June 1, 2007

By Diana Tucker

Hahnemann surgeons present MIS treatment for neck pain

June 1, 2007

By Diana Tucker

'No scar left behind' is a major benefit of NOTES procedure

May 30, 2007

By Diana Tucker

Big dollars, with increasing risk, driving new 'lifestyle' medicine

May 23, 2007

By Diana Tucker

View All Articles by Diana Tucker

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...